SCHEMBL17799645

SCHEMBL17799645

O=C(N[C@H]1CC[C@H]1c1ccc(Cl)cc1Cl)c1sccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 5/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ AGTR1 P30556 2/20 0.44
▸ MAPT P10636 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ CASP3 P42574 1/20 0.42
▸ SENP8 Q96LD8 1/20 0.42
▸ SENP7 Q9BQF6 1/20 0.42
▸ SENP6 Q9GZR1 1/20 0.42
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ F10 P00742 1/20 0.38
▸ DPP4 P27487 3/20 0.38
▸ TAS1R3 Q7RTX0 1/20 0.38
▸ TAS1R1 Q7RTX1 1/20 0.38
▸ TAS1R2 Q8TE23 1/20 0.38
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17799697 0.91 NPC1 (0.40) GAAALDH1A1AGTR1MAPTTDP1
SCHEMBL17799737 0.84 RAB9A (0.46) ALDH1A1NPC1RAB9ASMN1; SMN2F10
SCHEMBL17799671 0.84 GAA (0.50) GAAALDH1A1AGTR1MAPTTDP1
SCHEMBL17799763 0.82 RAB9A (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2F10
SCHEMBL17799675 0.82 RAB9A (0.44) ALDH1A1NPC1RAB9ASMN1; SMN2F10
SCHEMBL17799753 0.82 F10 (0.39) GAAALDH1A1AGTR1MAPTTDP1
SCHEMBL17799731 0.82 TSHR (0.54) GAAALDH1A1MAPTTDP1NPC1
SCHEMBL17799764 0.80 TAS1R3 (0.52) GAANPC1RAB9ADPP4TAS1R3
SCHEMBL20298618 0.79 P2RX7 (0.37) DPP4
SCHEMBL16220951 0.79 L3MBTL1 (0.57) NPC1RAB9APKMF10TAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE50724-E1 4-membered ring carboxamides used as nematicides SYNGENTA CROP PROTECTION AG (CH) 2026-01-06 — — US disclosed
EP-3019476-B1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2018-01-17 — — EP disclosed
US-9867371-B2 4-membered ring carboxamides used as nematicides SYNGENTA PARTICIPATIONS AG (CH) 2018-01-16 — — US disclosed
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES SYNGENTA PARTICIPATIONS AG (CH) 2016-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160157485-A1 4-MEMBERED RING CARBOXAMIDES USED AS NEMATICIDES TUBA3C, DDT, CYCS GAA 2228/4885ALDH1A1 1093/4885AGTR1 2968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback